Zoe Reece Named University of Auckland Alumni 40 Under 40 Recipient in Entrepreneur Category
In a groundbreaking move, Medsafe, New Zealand’s regulatory authority for medicines and medical devices, has recently reclassified Cannabidiol (CBD) from a prescription-only medicine to a restricted (pharmacist-only) medicine. This significant development signals a new era for accessible healthcare, offering promising avenues for patients and researchers alike.
We celebrate Ora Pharm’s fourth birthday with a sense of pride and gratitude. Time has flown by, and it feels like just yesterday when we embarked on this incredible journey. Today, we want to take a step back and reflect on the milestones, challenges, and achievements that have shaped Ora Pharm into the innovative pharmaceutical company it is today.
Medicinal Cannabis Sales in New Zealand: An Upward Trend
Press Release: Ora Pharm becomes one of the first approved direct investments under the new active investor visa plus category
Ora Pharm, a leading medical cannabis company, has become one of the first approved direct investments under the New Investor Visa category in New Zealand. The Active Investor Plus Visa category is designed to attract high net worth individuals who are willing to invest a significant amount of money in New Zealand’s economy, with the goal of creating jobs and fostering economic growth.
Ora Pharm Continues to Focus on Leading New Zealand’s Cannabis Market, R&D Grant from Callaghan Innovation
In June 2022, Ora Pharm was awarded a grant from Callaghan Innovation to develop new growing technology for the medicinal cannabis industry. The company are currently at the halfway mark of their trials and already seeing more than 40% increase in yield.
Stuart Wilcox (Ora Pharm Chair) and Blake Smith (Ora Pharm CSO), global medicinal cannabis experts were recently introduced to New Zealand as intergral members of the Ora Pharm team.
The use of cannabis as a medicinal plant has a long history dating back thousands of years. Read a short history of medicinal cannabis, its uses, potential benefits, and limitations.
Based on the forecasted growth rate of approximately 55%, it is estimated that over 56,000 packs of Medicinal Cannabis will be prescribed in New Zealand by the end of 2022.
Ora Pharm has been awarded a Callaghan Innovation Grant For Environmentally Friendly Innovative Technology to grow high-yield New Zealand Medicinal Cannabis.
Ora Pharm becomes the second international customer to invest in Vertical Farming Units as Agrify continues to gain momentum with its strategic global expansion efforts.
Where can you travel with CBD and medical cannabis? A list of countries with rules, regulations, and guidelines for travelling with CBD oil.
Antidepressants are among the most commonly prescribed medications and CBD is one of the fastest growing healthcare products on the planet. But are they safe to use together?
THC is known as the cannabis ingredient that gets you high, but does that mean it should be avoided? Explore the unique benefits of THC, CBD and medicinal cannabis.
Can CBD oil make you tired, hungry or paranoid? We myth-bust some of the common cannabis stereotypes and explain how CBD is different to THC.
Learn about the Entourage Effect, the remarkable theory that the compounds in medicinal cannabis work better together in the human body.
The natural flavours of CBD are only part of the story. Learn about the many factors that influence the taste of medicinal cannabis.
What are the benefits of full-spectrum CBD, broad-spectrum CBD, and CBD isolate. Learn all about the three different types of CBD oil.
Get the latest medicinal cannabis news, research, and company updates.